Follow The Filings

GEN Gen Digital Inc.

Information Technology, filed as Gen Digital Inc. (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 1 Owner
  • Max 2.5%
  • $199M
  • 1 exit 1 small

In 2026 Q2 Starboard Value sold out of Gen Digital.

Who owns this now

Largest portfolio weights among holders, up to 2.5% (Lyrical Asset Management). Not free-float ownership.

  1. Lyrical Asset Management Add 2.5%

Who owns GEN

Sorted by value, long equity only, as of 2026 Q2.

History
Lyrical Asset Management 2.5%, was 2.3% Small add +0.2% 7,983,428 $199M History
Starboard Value exited 2026 Q2 Last 2026 Q1 3.2% Exit −3.21% 7,806,922 $147M History

1 current, 1 exited last period, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by GEN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All GEN insider trades
  • $217K bought by 1 insider
  • $21.1M sold by 3 insiders outside a trading plan
  • $866K sold by 1 insider under 10b5-1 plans
  1. Bryan Seuk Ko COO
    Planned sale
    $866K 28,248 shares at $30.67 3.7% of stake
    Traded Sep 4 Filed Sep 9
    ↗
  2. Ondrej Vlcek Director
    Sale
    $6M 200,000 shares at $30.00 5.7% of stake
    Traded Aug 27 Filed Aug 28
    ↗
  3. Ondrej Vlcek Director
    Sale
    $4.4M 152,358 shares at $29.00 4.1% of stake
    Traded Aug 25 Filed Aug 27
    ↗
  4. Ondrej Vlcek Director
    Sale
    $1.4M 47,462 shares at $29.00 1.3% of stake
    Traded Aug 21 Filed Aug 25
    ↗
  5. Ondrej Vlcek Director
    Sale
    $2.8M 100,000 shares at $28.00 2.6% of stake
    Traded Aug 19 Filed Aug 21
    ↗
  6. Travis Michael Witteveen Head of Products and Portfolio
    Sale
    $12K 440 shares at $28.06 0.1% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  7. Travis Michael Witteveen Head of Products and Portfolio
    Sale
    $883K 30,000 shares at $29.42 5.7% of stake
    Traded Aug 10 Filed Aug 12
    ↗
  8. Ondrej Vlcek Director
    Sale
    $2.5M 100,000 shares at $24.78 2.5% of stake
    Traded Jun 10 Filed Jun 12
    ↗
  9. John C Chrystal Director
    Buy
    $81K 3,000 shares at $27.06 +11% to stake
    Traded Jun 4 Filed Jun 5
    ↗
  10. Natalie Marie Derse CFO
    Sale
    $19K 794 shares at $23.62 0.2% of stake
    Traded Feb 17 Filed Feb 19
    ↗
  11. Ondrej Vlcek Director
    Sale
    $3.1M 113,674 shares at $27.12 2.8% of stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
  12. John C Chrystal Director
    Buy
    $136K 5,000 shares at $27.14 +21% to stake
    Traded Nov 13, 2025 Filed Nov 14, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 stock grants, 13 share withholdings for taxes, 4 gifts, and 3 option exercises.

Congress

5 members of Congress traded GEN in the last three years: 4 buys and 4 sales. 4 members listed it in 2025 annual reports.

All Congress trades
  1. Julie Johnson D-TX-32Joint Sell $1K–$15K Oct 21, 2025 filed Aug 5
  2. Julie Johnson D-TX-32Joint Buy $1K–$15K Oct 21, 2025 filed Aug 5
  3. Alan Armstrong R-OK Buy $1K–$15K Mar 27 filed Jul 21
  4. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Apr 14 filed May 8
  5. Julie Johnson D-TX-32Joint Sell $1K–$15K Oct 22, 2025 filed Nov 14, 2025
  6. Val T. Hoyle D-OR-4Spouse Sell $1K–$15K Sep 23, 2025 filed Oct 10, 2025

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 5.07 Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
DEF 14A Filing Doc
DEFA14A DEFA 14A Filing Doc
10-K Filing Doc
8-K 2.02,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated about 19 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $3.34B $3.81B $3.94B $5B
Gross profit $2.75B $3.08B $3.16B $3.92B
Gross margin * 82.4% 80.8% 80.3% 78.5%
Net income $1.35B $0.616B $0.643B $0.973B
Net margin * 40.4% 16.2% 16.3% 19.5%

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $1.23B $1.36B $1.44B $1.08B
Total non-current assets * $14.71B $14.41B $14.05B $14.51B
Total assets $15.95B $15.77B $15.5B $15.59B
Total current liabilities $2.85B $2.65B $2.85B $2.71B
Total non-current liabilities * $10.9B $10.93B $10.38B $10.27B
Total equity $2.2B $2.2B $2.27B $2.61B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $0.757B $2.06B $1.22B $1.54B
Cash from investing -$6.55B $0.002B -$0.1B -$1.01B
Cash from financing $4.68B -$1.96B -$0.97B -$1.13B
Net change in cash -$1.14B $0.096B $0.16B -$0.595B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.